|
Volumn 45, Issue 9, 2001, Pages 2420-2426
|
In vitro and in vivo activities of Syn2836, Syn2869, Syn2903, and Syn2921: New series of triazole antifungal agents
a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
4 [4 [4 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 1 PIPERAZINYL]PHENYL] 2,4 DIHYDRO 2 [4 (TRIFLUOROMETHOXY)BENZYL] 1,2,4 TRIAZOL 3 ONE;
4 [4 [4 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 1 PIPERAZINYL]PHENYL] 2,4 DIHYDRO 2 [[4 (TRIFLUOROMETHYL)PHENYL]METHYL] 3H 1,2,4 TRIAZOL 3 ONE;
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
FLUCONAZOLE;
ITRACONAZOLE;
SYN 2903;
SYN 2921;
TRIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
ASPERGILLUS FUMIGATUS;
CANDIDA ALBICANS;
CONTROLLED STUDY;
CRYPTOCOCCUS NEOFORMANS;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG SYNTHESIS;
IN VITRO STUDY;
IN VIVO STUDY;
MICROSPORUM;
MINIMUM INHIBITORY CONCENTRATION;
MOULD;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SURVIVAL RATE;
TRICHOPHYTON;
YEAST;
ANIMALS;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
ASPERGILLUS;
CANDIDA ALBICANS;
CANDIDIASIS;
DISEASE MODELS, ANIMAL;
MICE;
MICROBIAL SENSITIVITY TESTS;
PIPERAZINES;
TREATMENT OUTCOME;
TRIAZOLES;
|
EID: 17944364840
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.45.9.2420-2426.2001 Document Type: Article |
Times cited : (11)
|
References (13)
|